378 related articles for article (PubMed ID: 24680112)
21. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in the radical nonsurgical treatment of stage IIIB non-small-cell lung cancer.
Russell K; Healy B; Pantarotto J; Laurie SA; MacRae R; Sabri E; Wheatley-Price P
Clin Lung Cancer; 2014 May; 15(3):237-43. PubMed ID: 24461300
[TBL] [Abstract][Full Text] [Related]
23. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
24. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
[TBL] [Abstract][Full Text] [Related]
25. [Skip metastasis to mediastinal lymph nodes: clinical significance and prognosis in stage III non-small cell lung cancer].
Chen QK; Ding JA; Gao W; Zhu YM
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):472-4. PubMed ID: 16115397
[TBL] [Abstract][Full Text] [Related]
26. [Bronchial cancer--development, diagnosis, therapy, prognosis].
Zöchbauer S; Krajnik G; Huber H
Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in stage III non-small-cell lung cancer.
Ademuyiwa FO; Johnson CS; White AS; Breen TE; Harvey J; Neubauer M; Hanna NH
Clin Lung Cancer; 2007 Sep; 8(8):478-82. PubMed ID: 17922971
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
Cancer J Sci Am; 1996; 2(2):99-105. PubMed ID: 9166507
[TBL] [Abstract][Full Text] [Related]
29. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
30. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
[TBL] [Abstract][Full Text] [Related]
31. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
32. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
[TBL] [Abstract][Full Text] [Related]
33. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with long-term survival of patients with advanced non-small cell lung cancer.
Giroux Leprieur E; Lavole A; Ruppert AM; Gounant V; Wislez M; Cadranel J; Milleron B
Respirology; 2012 Jan; 17(1):134-42. PubMed ID: 21943088
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer.
Arslan D; Tural D; Koca T; Tastekin D; Kaymak Cerkesli A; Basaran H; Gunduz S; Murat Tatli A; Sezgin Goksu S; Uysal M; Kargi A; Kargi B; Koral L; Ibrahim Bassorgun C; Unal D; Mutlu H; Senol Coskun H; Ozdogan M; Bozcuk H
J BUON; 2015; 20(2):573-9. PubMed ID: 26011352
[TBL] [Abstract][Full Text] [Related]
36. Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.
Al-Shamsi HO; Al Farsi A; Ellis PM
Clin Lung Cancer; 2014 Jul; 15(4):274-80. PubMed ID: 24685356
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors of advanced stage non-small-cell lung cancer.
Ben Amar J; Ben Safta B; Zaibi H; Dhahri B; Baccar MA; Azzabi S
Tunis Med; 2016 May; 94(5):360-367. PubMed ID: 27801487
[TBL] [Abstract][Full Text] [Related]
38. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997.
Foeglé J; Hédelin G; Lebitasy MP; Purohit A; Velten M; Quoix E
J Thorac Oncol; 2007 Jun; 2(6):466-74. PubMed ID: 17545840
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy.
Oh D; Ahn YC; Park HC; Lim DH; Noh JM; Cho WK; Pyo H
Oncotarget; 2017 May; 8(22):35700-35706. PubMed ID: 28415687
[TBL] [Abstract][Full Text] [Related]
40. [Metastatic non-small cell lung cancer: a Tunisian retrospective study about 100 cases].
Chaari A; Ben Nasr S; Labidi S; Afrit M; Boussen H
Tunis Med; 2015 May; 93(5):294-6. PubMed ID: 26578045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
